Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Tandem Diabetes Care (TNDM) over the last 7 years, with Q3 2025 value amounting to $64.9 million.

  • Tandem Diabetes Care's Long-Term Investments changed N/A to $64.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.9 million, marking a year-over-year change of. This contributed to the annual value of $74.5 million for FY2024, which is N/A changed from last year.
  • Per Tandem Diabetes Care's latest filing, its Long-Term Investments stood at $64.9 million for Q3 2025.
  • Tandem Diabetes Care's Long-Term Investments' 5-year high stood at $74.5 million during Q4 2024, with a 5-year trough of $64.9 million in Q3 2025.